197 related articles for article (PubMed ID: 28709429)
21. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.
Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S
Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067
[TBL] [Abstract][Full Text] [Related]
22. Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series.
Bourgault S; Baril C; Vincent A; Héon E; Ali A; MacDonald I; Lueder GT; Colleaux KM; Laliberté I
Br J Ophthalmol; 2015 Nov; 99(11):1536-42. PubMed ID: 25926518
[TBL] [Abstract][Full Text] [Related]
23. Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases.
Khanna S; Martins A; Oakey Z; Mititelu M
J Ophthalmic Inflamm Infect; 2019 Feb; 9(1):6. PubMed ID: 30806850
[TBL] [Abstract][Full Text] [Related]
24. Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab.
Falter T; Herold S; Weyer-Elberich V; Scheiner C; Schmitt V; von Auer C; Messmer X; Wild P; Lackner KJ; Lämmle B; Scharrer I
Thromb Haemost; 2018 Oct; 118(10):1743-1751. PubMed ID: 30235478
[TBL] [Abstract][Full Text] [Related]
25. A Man with Paraneoplastic Retinopathy plus Small Fiber Polyneuropathy Associated with Waldenström Macroglobulinemia (Lymphoplasmacytic Lymphoma): Insights into Mechanisms.
Liu Y; Magro C; Loewenstein JI; Makar RS; Stowell CP; Dzik WH; Hochberg EP; Oaklander AL; Sobrin L
Ocul Immunol Inflamm; 2015; 23(5):405-9. PubMed ID: 24654565
[TBL] [Abstract][Full Text] [Related]
26. [Review of the current use of rituximab during 4 years in a French university hospital].
Reynaud Q; Killian M; Robles A; Mounsef F; Camdessanché JP; Mariat C; Cathébras P
Rev Med Interne; 2015 Dec; 36(12):800-12. PubMed ID: 26318843
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune retinopathy: clinical, electrophysiological, and immunological features in nine patients with long-term follow-up.
Safadi K; Chowers I; Banin E; Rosin B; Tiosano L; Amer R
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):975-991. PubMed ID: 34591174
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
J Autoimmun; 2015 Feb; 57():24-9. PubMed ID: 25586449
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and Therapeutic Challenges.
Liu H; Luo Y; Duan M; Zhang J; Cantrill HL
Retina; 2017 Jul; 37(7):1415-1418. PubMed ID: 27749496
[No Abstract] [Full Text] [Related]
30. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).
Scheinberg M; Hamerschlak N; Kutner JM; Ribeiro AA; Ferreira E; Goldenberg J; Kiss MH; Chahade WH
Clin Exp Rheumatol; 2006; 24(1):65-9. PubMed ID: 16539821
[TBL] [Abstract][Full Text] [Related]
31. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
32. Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy.
Maleki A; Lamba N; Ma L; Lee S; Schmidt A; Foster CS
Clin Ophthalmol; 2017; 11():377-385. PubMed ID: 28255228
[TBL] [Abstract][Full Text] [Related]
33. Rituximab in autoimmune connective tissue disease-associated interstitial lung disease.
Sharp C; McCabe M; Dodds N; Edey A; Mayers L; Adamali H; Millar AB; Gunawardena H
Rheumatology (Oxford); 2016 Jul; 55(7):1318-24. PubMed ID: 27060110
[TBL] [Abstract][Full Text] [Related]
34. Rituximab for the treatment of autoimmune subepidermal blistering diseases.
Riquelme-Mc Loughlin C; Estrach T; Morgado-Carrasco D; Fustà-Novell X; Riera-Monroig J; Iranzo P
Dermatol Ther; 2018 Sep; 31(5):e12687. PubMed ID: 30207027
[No Abstract] [Full Text] [Related]
35. B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
Fluge Ø; Risa K; Lunde S; Alme K; Rekeland IG; Sapkota D; Kristoffersen EK; Sørland K; Bruland O; Dahl O; Mella O
PLoS One; 2015; 10(7):e0129898. PubMed ID: 26132314
[TBL] [Abstract][Full Text] [Related]
36. SD-OCT and autofluorescence characteristics of autoimmune retinopathy.
Pepple KL; Cusick M; Jaffe GJ; Mruthyunjaya P
Br J Ophthalmol; 2013 Feb; 97(2):139-44. PubMed ID: 23221966
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune retinopathy.
Braithwaite T; Vugler A; Tufail A
Ophthalmologica; 2012; 228(3):131-42. PubMed ID: 22846442
[TBL] [Abstract][Full Text] [Related]
38. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
[TBL] [Abstract][Full Text] [Related]
39. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.
Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
J Autoimmun; 2015 Feb; 57():60-5. PubMed ID: 25556904
[TBL] [Abstract][Full Text] [Related]
40. A clinical triad to diagnose paraneoplastic retinopathy.
Jacobson DM; Thirkill CE; Tipping SJ
Ann Neurol; 1990 Aug; 28(2):162-7. PubMed ID: 2171418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
